Comparative study between simvastatin and simvastatin/ezetimibe with equivalent cholesterol reduction: Same benefits?

被引：0
|
作者：
De Araujo, Daniel Branco [1 ,2 ]
Bertolami, Marcelo Chiara [1 ,2 ]
Ferreira, Waldinai Pereira [1 ,2 ]
Abdalla, Dulcineia Saes Parra [1 ,2 ]
Faludi, Andre Arpad [1 ,2 ]
Nakamura, Yara [1 ,2 ]
Bricarelo, Liliana Paula [1 ,2 ]
机构：
[1] Inst Dante Pazzanese Cardiol, Sao Paulo, SP, Brazil
[2] Inst Coracao, Sao Paulo, SP, Brazil
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2007年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(07)71968-2
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [31] Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia
    Assmann, Gerd
    Kannenberg, Frank
    Ramey, Dena R.
    Musliner, Thomas A.
    Gutkin, Stephen W.
    Veltri, Enrico P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (01) : 249 - 259
  • [32] Enhanced cholesterol reduction by simvastatin in diltiazem-treated patients
    Yeo, KR
    Yeo, WW
    Wallis, EJ
    Ramsay, LE
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (04) : 610 - 615
  • [33] Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study)
    Gianluca Bardini
    Carlo B Giorda
    Antonio E Pontiroli
    Cristina Le Grazie
    Carlo M Rotella
    Cardiovascular Diabetology, 9
  • [34] Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study
    Pedersen, TR
    Berg, K
    Cook, TJ
    Faergeman, O
    Haghfelt, T
    Kjekshus, J
    Miettinen, T
    Musliner, TA
    Olsson, AG
    Pyorala, K
    Thorgeirsson, G
    Tobert, JA
    Wedel, H
    Wilhelmsen, L
    ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (18) : 2085 - 2092
  • [35] Comparative efficacy of ezetimibe plus simvastatin combined therapy vs. simvastatin monotherapy for individuals with reduced estimated glomerular filtration rate
    Stanifer, J. W.
    Charytan, D. M.
    White, J.
    Lokhnygina, Y.
    Cannon, C.
    Blazing, M. A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1205 - 1205
  • [36] RANDOMIZED COMPARISON OF ROSUVASTATIN PLUS EZETIMIBE VERSUS SIMVASTATIN PLUS EZETIMIBE: RESULTS OF THE GRAVITY STUDY
    Ballantyne, Christie M.
    Schiebinger, Rick
    Cain, Valerie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [37] A RANDOMIZED COMPARISON OF ROSUVASTATIN PLUS EZETIMIBE VERSUS SIMVASTATIN PLUS EZETIMIBE: RESULTS OF THE GRAVITY STUDY
    Ballantyne, C. M.
    Schiebinger, R.
    Cain, V.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 69 - 69
  • [38] RELATIVE RESPONSIVENESS TO LDL-LOWERING AGENTS THAT BLOCK CHOLESTEROL ABSORPTION (EZETIMIBE) AND INHIBIT CHOLESTEROL SYNTHESIS (SIMVASTATIN)
    Lakoski, S. G.
    Vega, G. L.
    Grundy, S. M.
    Chandalia, M.
    Lam, C.
    Lowe, R. S.
    Stepanavage, M. E.
    Musliner, T. A.
    Cohen, J. C.
    Hobbs, H. H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 80 - 80
  • [39] STROKE IN PATIENTS WITH AORTIC STENOSIS: THE SIMVASTATIN AND EZETIMIBE IN AORTIC STENOSIS STUDY
    Greve, Anders M.
    Dalsgaard, Morten
    Bang, Casper
    Egstrup, Kenneth
    Ray, Simon
    Boman, Kurt
    Rossebo, Anne B.
    Gohlke-Baerwolf, Christa
    Devereux, Richard
    Kober, Lars
    Wachtell, Kristian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A2017 - A2017
  • [40] Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study
    Rossebo, Anne B.
    Pedersen, Terje R.
    Allen, Christopher
    Boman, Kurt
    Chambers, John
    Egstrup, Kenneth
    Gerdts, Eva
    Gohlke-Barwolf, Christa
    Holme, Ingar
    Kesaniemi, V. Antero Y.
    Malbecq, William
    Nienaber, Christoph
    Ray, Simon
    Skjærpe, Terje
    Wachtell, Kristian
    Willenheimer, Ronnie
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (07): : 970 - 973
12345